NCT07442851Recruiting
SickleFit Exercise and Nutrition Study
The SickleFit Exercise and Nutrition Randomized Control Trial for Older Adults With Sickle Cell Disease
Source: ClinicalTrials.gov · Last updated 7 May 2026
Brief summary (registry, in English)
To goal of this study is to pilot the SickleFit exercise and nutrition intervention in adults with sickle cell disease in a randomized control trial
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 20 Feb 2026
- Start date
- 8 Apr 2026
- Primary completion date
- Jan 2028
- Lead sponsor
- Duke University
- Diseases
- Sickle cell disease
- NCT number
- NCT07442851
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 8 Apr 2026 to the primary completion date, Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Successfully treated with hematopoietic stem cell transplantation or gene therapy for sickle cell disease
Other illness
- Unstable cardiac disease
- Diagnosed with severe cognitive impairment based on ICD-10 codes or reported by their outpatient provider
- Severe uncorrected visual or auditory impairment
Other
- Oxygen dependence
- Wheelchair-bound
- Unable to self-consent
- Pregnant
Who the study is looking for
- Laboratory-confirmed diagnosis of sickle cell disease (any genotype)
- Understand and speak English by self-report
- Age ≥ 35 years old
Age in the registry: 35 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Duke University Coordinator of this site? Confirm its status | Durham | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.